Edition:
United States

Kindred Biosciences Inc (KIN.OQ)

KIN.OQ on NASDAQ Stock Exchange Capital Market

8.55USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$8.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,766
52-wk High
$9.80
52-wk Low
$5.00

Latest Key Developments (Source: Significant Developments)

KindredBio Announces Submission Of European Medicines Agency Filing For Mirataz
Thursday, 21 Dec 2017 08:02am EST 

Dec 21 (Reuters) - Kindred Biosciences Inc ::KINDREDBIO ANNOUNCES SUBMISSION OF EUROPEAN MEDICINES AGENCY FILING FOR MIRATAZ™.KINDRED BIOSCIENCES INC - EMA HAS ACCEPTED SUBMISSION FOR REVIEW, WITH OFFICIAL ACCEPTANCE DATE OF DECEMBER 21, 2017.KINDRED BIOSCIENCES INC - EXECUTED NATIONAL DISTRIBUTION DEALS WITH MWI VETERINARY SUPPLY CO. & DIRECT VET MARKETING, INC. D/B/A VETS FIRST CHOICE.  Full Article

KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral
Monday, 4 Dec 2017 08:02am EST 

Dec 4 (Reuters) - Kindred Biosciences Inc ::KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES.KINDRED BIOSCIENCES INC - ‍BASED ON PRELIMINARY REVIEW OF SAFETY DATA, DRUG ZIMETA APPEARS TO BE WELL TOLERATED ​.KINDRED BIOSCIENCES INC - CO ANTICIPATES SUBMITTING EFFECTIVENESS TECHNICAL SECTION OF NEW ANIMAL DRUG APPLICATION IN EARLY 2018​.  Full Article

Kindred Biosciences posts Q3 loss of $0.29 per share
Tuesday, 7 Nov 2017 04:01pm EST 

Nov 7 (Reuters) - Kindred Biosciences Inc :Kindred biosciences announces third quarter 2017 financial results.Q3 loss per share $0.29.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.  Full Article

Kindred Biosciences Q2 loss per share $0.29
Monday, 7 Aug 2017 04:01pm EDT 

Aug 7 (Reuters) - Kindred Biosciences Inc :Kindred Biosciences announces second quarter 2017 financial results.Q2 loss per share $0.29.Q2 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.Kindred Biosciences - ‍for 2017 , reiterates its previous guidance for operating expenses to be in range of $30 million to $32 million, excluding items​.  Full Article

Kindred Biosciences says board appointed Wendy Wee as CFO - SEC Filing
Friday, 28 Jul 2017 05:19pm EDT 

July 28 (Reuters) - Kindred Biosciences Inc :Kindred Biosciences Inc - On July 24, 2017, board of directors of co appointed Wendy Wee as CFO of company, effective July 28, 2017 - SEC Filing.Kindred Biosciences Inc - As of July 28, 2017, date of Wee's appointment as CFO, Richard Chin no longer serves as interim chief financial officer.  Full Article

KindredBio announces pricing of public offering
Wednesday, 12 Jul 2017 08:40am EDT 

July 12 (Reuters) - Kindred Biosciences Inc :KindredBio announces pricing of public offering.Says public offering of 3.00 million common shares priced at $7.50 per share.  Full Article

Kindredbio announces proposed public offering of common stock
Tuesday, 11 Jul 2017 04:10pm EDT 

July 11 (Reuters) - Kindred Biosciences Inc :Kindredbio announces proposed public offering of common stock.Kindred Biosciences-intends to use net proceeds for expansion of commercial infrastructure in anticipation of future product approvals, launches.Kindred Biosciences Inc - also intends to use net proceeds for expansion of its manufacturing capacity, development of its therapeutic candidates.  Full Article

Kindred Biosciences reports acquisition of Kansas manufacturing plant
Monday, 26 Jun 2017 07:30am EDT 

June 26 (Reuters) - Kindred Biosciences Inc ::Kindred Biosciences announces acquisition of Kansas manufacturing plant and execution of commercial manufacturing agreement for Zimeta.Kindred Biosciences announces acquisition of Kansas manufacturing plant and execution of commercial manufacturing agreement for Zimeta.Kindred Biosciences Inc - total purchase price was $3.75 million.Kindred Biosciences Inc says ‍also announced execution of a commercial manufacturing agreement with Corden Pharma S.P.A for manufacture of Zimeta​.Kindred Biosciences - agreement with Corden Pharma is for initial 3-year term, permits for automatic renewal period of 2-years upon conclusion of initial term.Says ‍company also announced completion of its ATM financing​.  Full Article

Kindred Biosciences announces Q1 loss per share $0.30
Wednesday, 3 May 2017 04:01pm EDT 

May 3 (Reuters) - Kindred Biosciences Inc :Kindred Biosciences announces first quarter 2017 financial results.Q1 loss per share $0.30.Kindred Biosciences Inc says for 2017 calendar year, company reiterates its previous guidance for operating expenses to be in range of $30 million to $32 million.  Full Article

Kindred Biosciences Q4 loss per share $0.29
Wednesday, 1 Mar 2017 04:01pm EST 

Kindred Biosciences Inc : Kindred biosciences announces fourth quarter and year-end 2016 financial results . Q4 loss per share $0.29 .Q4 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Kindred Biosciences Inc Files For Mixed Shelf Of Up To $150 Million

* KINDRED BIOSCIENCES INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text - (http://bit.ly/2risHPv) Further company coverage: